{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:41:51Z","timestamp":1794004911270,"version":"4.8.0"},"update-to":[{"DOI":"10.1002\/14651858.cd001750.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T00:00:00Z","timestamp":1461888000000}}],"reference-count":176,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001750.pub4","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T09:19:49Z","timestamp":1462007989000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":153,"title":["Gonadotrophin-releasing hormone antagonists for assisted reproductive technology"],"prefix":"10.1002","volume":"2016","author":[{"given":"Hesham G","family":"Al-Inany","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Cairo University; Department of Obstetrics & Gynaecology; 8 Moustapha Hassanin St Manial Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A","family":"Youssef","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Cairo University; Department of Obstetrics & Gynaecology; 8 Moustapha Hassanin St Manial Cairo Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben Olugbenga","family":"Ayeleke","sequence":"additional","affiliation":[{"name":"University of Auckland; Department of Obstetrics and Gynaecology; Private Bag 92019 Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Brown","sequence":"additional","affiliation":[{"name":"The University of Auckland; Liggins Institute; Park Rd Grafton Auckland New Zealand 1142"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Sun","family":"Lam","sequence":"additional","affiliation":[{"name":"University of Auckland; Department of Obstetrics and Gynaecology; Private Bag 92019 Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J","family":"Broekmans","sequence":"additional","affiliation":[{"name":"University Medical Center; Department of Reproductive Medicine and Gynecology; Utrecht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,4,29]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","article-title":"Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserlin","volume":"15","author":"Albano","year":"2000","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/PL00007479","article-title":"Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction","volume":"264","author":"Ludwig","year":"2000","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0003|cit3","first-page":"i47","article-title":"Effectiveness of flexible GnRH antagonist protocol versus minidose long GnRH agonist protocol in poor-responder patients undergoing IVF","volume":"26","author":"Al-Karaki","year":"2011","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"Anderson S Pereira NE Brasile DR Orris JJ Davies EB Glassner MJ Comparison of antagonist to agonist in controlled ovarian stimulation (COS) cycles using human-derived gonadotropin on in vitro fertilization (IVF) outcomes. A prospective randomized controlled study Fertility and sterility 2014 e224","DOI":"10.1016\/j.fertnstert.2014.07.759"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"S164 Abstract n","DOI":"10.1016\/j.fertnstert.2010.07.652","article-title":"Selection of an optimal controlled ovarian hyperstimulation method in relation to the number of antral follicles in patients less than 40 years old","volume":"94 suppl 1","author":"Awata","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/humrep\/del484","article-title":"Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial","volume":"22","author":"Baart","year":"2007","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0007|cit7","first-page":"49","article-title":"Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis","volume":"10","author":"Badrawi","year":"2005","journal-title":"Middle East Fertility Society Journal"},{"issue":"2","key":"10.1002\/14651858.CD001750.pub4-BIB0008|cit8","first-page":"84","article-title":"Use of a GnRH antagonist in controlled ovarian hyperstimulation for assisted conception in women with polycystic ovary disease: a randomized, prospective, pilot study","volume":"50","author":"Bahceci","year":"2005","journal-title":"Journal of Reproductive Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001750.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.fertnstert.2004.06.076","article-title":"A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist\/recombinant follicle-stimulating hormone (r FSH) versus GnRH-agonist\/r FSH in women pretreated with oral contraceptives before in vitro fertilization","volume":"83","author":"Barmat","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0010|cit10","first-page":"i62","article-title":"Assessment of the predictive value of LH levels in IVF cycles stimulated with GnRH antagonists and agonists","volume":"19","author":"Brelik","year":"2004","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0011|cit11","first-page":"i203","article-title":"Plasma urocortin levels in women undergoing long agonist and antagonist protocols for IVF","volume":"26","author":"Celik","year":"2011","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0012|cit12","first-page":"257","article-title":"Effect of antagonists vs agonists on in vitro fertilization outcome","volume":"31","author":"Check","year":"2004","journal-title":"Clinical and Experimental Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/humrep\/deh668","article-title":"GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial","volume":"20","author":"Cheung","year":"2005","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.5653\/cerm.2012.39.4.166","article-title":"IVF comparison of ART outcomes in infertile PCOS women; in vitro maturation (IVM) vs. GnRH agonist vs. GnRH antagonist cycles","volume":"39","author":"Choi","year":"December 2012","journal-title":"Clinical Experimental Reproductive Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5653\/cerm.2012.39.4.166","article-title":"Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: In vitro maturation, GnRH agonist, and GnRH antagonist cycles","volume":"39","author":"Choi","year":"2012","journal-title":"Clinical & Experimental Reproductive Medicine"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1477-7827-10-33","article-title":"GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology","volume":"10","author":"Cota","year":"2012","journal-title":"Reproductive Biology and Endocrinology"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2012.07.014","article-title":"GnRH agonist versus GnRH antagonist in IVF\/ICSI cycles with recombinant LH supplementation: DNA fragmentation and apoptosis granulosa cells","volume":"165","author":"Lavorato","year":"2012","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"5","key":"10.1002\/14651858.CD001750.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/09513590802617762","article-title":"Follicular growth and oocyte maturation in GnRH agonist and antagonist protocols for in vitro fertilisation and embryo transfer","volume":"25","author":"Depalo","year":"2009","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0019|cit19","unstructured":"El Sahwi S GnRH agonists versus GnRH antagonists in controlled ovarian stimulation in ICSI trials Book of Abstracts, 8th International Symposium on GnRH Analogues in Cancer and Human Reproduction. Salzburg, Austria 2005 A65"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","article-title":"The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospsective randomised controlled study","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/humrep\/16.4.644","article-title":"Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation","volume":"16","author":"European and Middle East Orgalutran Study Group","year":"2001","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"7","key":"10.1002\/14651858.CD001750.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/B:JARG.0000042010.86102.03","article-title":"Association of inhibin B serum levels with parameters of follicular response in a randomized controlled trial comparing GnRH agonist versus antagonist protocols for ovarian hyperstimulation","volume":"21","author":"Sonntag","year":"2004","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0023|cit23","first-page":"1490","article-title":"Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial","volume":"7","author":"Borm","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejogrb.2005.08.017","article-title":"Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist\/FSH ovarian stimulation cycles","volume":"124","author":"Ferrari","year":"2006","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"6","key":"10.1002\/14651858.CD001750.pub4-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/09513590600777602","article-title":"Gonadotrophin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-I and vascular endothelial growth factor during ovarian stimulation cycles","volume":"22","author":"Ferrari","year":"June 2006","journal-title":"Gynecological Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"S28 Abstract no","DOI":"10.1016\/j.fertnstert.2010.07.106","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients at high risk of ovarian hyperstimulation syndrome: A prospective randomized controlled trial","volume":"94 suppl 1","author":"Ferrero","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00404-009-1073-5","article-title":"Comparing GnRH agonist long protocol and GnRH antagonist protocol in outcome the first cycle of ART","volume":"281","author":"Firouzabadi","year":"2010","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0015-0282(00)01638-1","article-title":"Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation","volume":"75","author":"Fluker","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0029|cit29","first-page":"26","article-title":"Comparison of ovarian stimulation with recombinant FSH After 2nd phase protocols with GnRH Analogs (I-estradiol + ganirelix versus II-nafarelin)","volume":"7","author":"Franco Jr","year":"2003","journal-title":"Jornal Brasileiro de Reproducao Assistida"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0030|cit30","first-page":"26","article-title":"Luteal phase characteristics following GnRH antagonist or agonist treatment: a randomized comparative study","volume":"18 Suppl 1","author":"Friedler","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"12","key":"10.1002\/14651858.CD001750.pub4-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3109\/09513590.2014.964638","article-title":"Which luteal phase support is better for each IVF stimulation protocol to achieve the highest pregnancy rate? A superiority randomized clinical trial","volume":"30","author":"Gizzo","year":"2014","journal-title":"Gynecological Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00404-012-2348-9","article-title":"IVF\/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial","volume":"286","author":"Haydardedeoglu","year":"September 2012","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(07)60360-2","article-title":"A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial","volume":"369","author":"Heijnen","year":"2007","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejogrb.2014.12.021","article-title":"GnRH-antagonist programming versus GnRH agonist protocol: a randomized trial","volume":"185","author":"Hershko Klement","year":"2015","journal-title":"European Journal of Obstetrics Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0035|cit35","doi-asserted-by":"crossref","unstructured":"Hershko Klement A Berkovitz A Wiser A Gonen O Amichay K Shulman A Follicular estrogen for GnRH-antagonist protocol programming: a prospective randomized clinical trial Fertility and Sterility 2013 S523","DOI":"10.1016\/j.fertnstert.2013.07.263"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1210\/jc.2002-020788","article-title":"A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol","volume":"88","author":"Hohmann","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0037|cit37","first-page":"67","article-title":"A randomized controlled trial of gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression","volume":"22","author":"Hoseini","year":"2014","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1447-0756.2010.01247.x","article-title":"Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients","volume":"36","author":"Hosseini","year":"2010","journal-title":"Journal of Obstetrics & Gynaecology Research"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1028-4559(08)60057-1","article-title":"Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization","volume":"47","author":"Hsieh","year":"2008","journal-title":"Taiwan Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD001750.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1472-6483(10)60621-9","article-title":"Effect of an oral contraceptive pill on follicular development in IVF\/ICSI patients receiving a GnRH antagonist: a randomized study","volume":"13","author":"Huirne","year":"2006","journal-title":"Reproductive Biomedicine Online"},{"issue":"9","key":"10.1002\/14651858.CD001750.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/humrep\/deh375","article-title":"Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study","volume":"19","author":"Hwang","year":"2004","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.fertnstert.2004.07.619","article-title":"Reproductive performance in second IVF cycles treated with the use of either GnRH antagonists (-antag) vs GnRH agonists (-ag) after failure with long protocols with GnRH agonists: a prospective randomized trial","volume":"82 Suppl","author":"Inza","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00404-009-1252-4","article-title":"Comparison of mild stimulation and conventional stimulation in ART outcome","volume":"281","author":"Karimzadeh","year":"2010","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.rbmo.2010.03.017","article-title":"GnRH agonist and GnRH antagonist protocols in ovarian stimulation: differential regulation pathway of aromatase expression in human granulosa cells","volume":"21","author":"Khalaf","year":"2010","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0045|cit45","first-page":"i104","article-title":"Efficacy of a GnRH antagonist during early and late controlled ovarian hyperstimulation period in women with polycystic ovary syndrome undergoing IVF-ET","volume":"19","author":"Kim","year":"2004","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD001750.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.fertnstert.2009.05.013","article-title":"Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF\/intracytoplasmic sperm injection","volume":"92","author":"Kim","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5653\/cerm.2011.38.4.228","article-title":"GnRH antagonist multiple dose protocol with oral contraceptive pill pre-treatment in poor responders undergoing IVF\/ICSI","volume":"38","author":"Kim","year":"2011","journal-title":"Clinical and Experimental Reproductive Medicine"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0048|cit48","unstructured":"Kim CH Lee HA Lee JW Lee YJ Nah HY Hong SH The efficacy of oral contraceptive pretreatment in controlled ovarian hyperstimulation using a GnRH antagonist for low responders [poster]. Abstracts of the 21st Annual Meeting of the ESHRE. Copenhagen, Denmark, 2005 Human Reproduction 2005 i105 6"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5653\/cerm.2012.39.1.22","article-title":"Effectiveness of GnRH antagonist multiple dose protocol applied during early and late follicular phase compared with GnRH agonist long protocol in non-obese and obese patients with polycystic ovary syndrome undergoing IVF\/ICSI","volume":"39","author":"Kim","year":"2012","journal-title":"Clinical and Experimental Reproductive Medicine"},{"issue":"8","key":"10.1002\/14651858.CD001750.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10815-008-9249-7","article-title":"Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study","volume":"25","author":"Kurzawa","year":"2008","journal-title":"Journal for Assisted Reproduction and Genetics"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.fertnstert.2004.07.084","article-title":"A prospective randomized study of three ovulation induction protocols for IVF: GnRH agonist versus antagonist with and without low dose hCG","volume":"82 Suppl","author":"Kyono","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.fertnstert.2005.07.780","article-title":"A prospective randomized study of three different controlled ovarian hyperstimulation (COH) protocols","volume":"84 Suppl 1","author":"Kyono","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD001750.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/humrep\/dem033","article-title":"Initiation of GnRH antagonist on day 1 of stimulation as compared to the long agonist protocol in PCOS patients: a randomised controlled trial: effect on hormonal levels and follicular development","volume":"22","author":"Lainas","year":"2007","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0054|cit54","first-page":"1","article-title":"Flexible Gnrh antagonist protocol versus Gnrh agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)","volume":"16","author":"Basly","year":"2012","journal-title":"Internet Journal of Gynecology & Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/dep436","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)","volume":"25","author":"Lainas","year":"2010","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2012.07.014","article-title":"GnRH agonist versus GnRH antagonist in IVF\/ICSI cycles with recombinant LH supplementation: DNA fragmentation and apoptosis in granulosa cells","volume":"165","author":"Lavorato","year":"2012","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"6","key":"10.1002\/14651858.CD001750.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.fertnstert.2004.12.037","article-title":"Ovarian response and follicular development for single-dose and multiple-dose protocols for gonadotropin-releasing hormone antagonist administration","volume":"83","author":"Lee","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD001750.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/09513590600702733","article-title":"Comparison of outcome of clomiphene citrate\/human menopausal gonadotropin\/cetrorelix protocol and buserelin long protocol - a randomized study","volume":"22","author":"Lin","year":"2006","journal-title":"Gynecological Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD001750.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.fertnstert.2004.04.051","article-title":"A modified gonadotropin-releasing hormone (GnRH) antagonist protocol failed to increase clinical pregnancy rates in comparison with the long GnRH protocol","volume":"82","author":"Loutradis","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD001750.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1472-6483(10)60957-1","article-title":"GnRH antagonist in IVF poor-responder patients: results of a randomized trial","volume":"11","author":"Marci","year":"2005","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0061|cit61","first-page":"115","article-title":"The use of GnRH antagonist in ovarian stimulation for IVF cycles can achieve good pregnancy rates in poor responder patients","volume":"17","author":"Marci","year":"2002","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/09513590801893331","article-title":"Prospective, randomized, comparative study of leuprorelin + human menopausal gonadotropins versus ganirelix + recombinant follicle-stimulating hormone in oocyte donors and pregnancy rates among the corresponding recipients","volume":"24","author":"Mart\u00ednez","year":"2008","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD001750.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/09513590500519260","article-title":"Effect of gonadotropin-releasing hormone agonist and antagonist on steroidogenesis of low responders undergoing in vitro fertilization","volume":"22","author":"Mohamed","year":"2006","journal-title":"Gynecological Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12325-008-0028-8","article-title":"Comparison of GnRH agonists and antagonists in normo-responder IVF\/ICSI in Turkish female patients","volume":"25","author":"Moraloglu","year":"2008","journal-title":"Advances in Therapy"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0065|cit65","first-page":"i121","article-title":"GnRH antagonist versus long GnRH agonists protocol in PCOS patients undergoing IVF treatment","volume":"22 Suppl 1","author":"Moshin","year":"2007","journal-title":"Abstracts of the 23rd Annual Meeting of the ESHRE, Lyon, France"},{"issue":"2","key":"10.1002\/14651858.CD001750.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0015-0282(99)00524-5","article-title":"Prospective randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)","volume":"73","author":"Olivennes","year":"2000","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD001750.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/humrep\/des066","article-title":"GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study","volume":"27","author":"Papanikolaou","year":"2012","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejogrb.2012.09.008","article-title":"GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial","volume":"166","author":"Prapas","year":"2013","journal-title":"European Journal of Obstetrics, Gynecology, & Reproductive Biology"},{"issue":"10","key":"10.1002\/14651858.CD001750.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3109\/09513590.2012.665103","article-title":"A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates","volume":"28","author":"Qiao","year":"2012","journal-title":"Gynecological Endocrinology"},{"issue":"11","key":"10.1002\/14651858.CD001750.pub4-BIB0070|cit70","first-page":"1063","article-title":"Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol","volume":"17","author":"Rabati","year":"2012","journal-title":"Journal of Research in Medical Sciences"},{"issue":"7","key":"10.1002\/14651858.CD001750.pub4-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s10815-014-0227-y","article-title":"\u201cMild\u201d vs. \u201clong\u201d protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial","volume":"31","author":"Revelli","year":"July 2014","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40618-013-0021-1","article-title":"Mild\/minimal stimulation protocol for ovarian stimulation of patients at high risk of developing ovarian hyperstimulation syndrome","volume":"37","author":"Rinaldi","year":"2014","journal-title":"Journal of Endocrinological Investigation"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/humrep\/dei302","article-title":"A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients","volume":"21","author":"Rombauts","year":"2006","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD001750.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1472-6483(10)61631-8","article-title":"Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction","volume":"9","author":"Sauer","year":"2004","journal-title":"Reproductive Biomedicine Online"},{"issue":"5","key":"10.1002\/14651858.CD001750.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.fertnstert.2008.02.165","article-title":"Cetrorelix protocol versus gonadotropin-releasing hormone analog suppression long protocol for superovulation in intracytoplasmic sperm injection patients older than 40","volume":"91","author":"Sbracia","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0076|cit76","first-page":"1","article-title":"A prospective, randomized trial of three ovulation induction protocols for IVF including a novel approach with low-dose HCG and GnRH antagonist in the mid-late follicular phase","volume":"18","author":"Serafini","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.fertnstert.2006.02.110","article-title":"Ovarian stimulation with daily late follicular phase administration of low dose human chorionic gonadotropin for in vitro fertilization: a prospective randomized trial","volume":"86","author":"Serafini","year":"2006","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/humrep\/deu294","article-title":"Mental distress and personality in women undergoing GnRH agonist versus GnRH antagonist protocols for assisted reproductive technology","volume":"30","author":"Stenbaek","year":"2015","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0079|cit79","unstructured":"Sunkara S Coomarasamy A Faris R Braude P Khalaf Y Effectiveness of the GnRH agonist long, GnRH agonist short and GnRH antagonist regimens in poor responders undergoing IVF treatment: a three arm randomised controlled trial Human Reproduction 2013 i348"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.fertnstert.2013.09.035","article-title":"Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: A randomized controlled trial","volume":"101","author":"Sunkara","year":"2014","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD001750.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00404-008-0620-9","article-title":"Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing in vitro fertilization: a randomized controlled trial","volume":"278","author":"Tazeg\u00fcl","year":"2008","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00404-010-1429-x","article-title":"Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients","volume":"282","author":"Tehraninejad","year":"2010","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0083|cit83","first-page":"106","article-title":"GnRH Antagonist versus Agonist in Normoresponders Undergoing ICSI: A Randomized Clinical Trial in Iran","volume":"7","author":"Nezamabadi","year":"2013","journal-title":"International Journal of Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0084|cit84","first-page":"171","article-title":"GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran","volume":"9","author":"Tehraninejad","year":"2011","journal-title":"Iranian Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0085|cit85","doi-asserted-by":"crossref","unstructured":"Toltager M Bogstad J Lossl K Pregnancy rates and risk of ovarian hyperstimulation syndrome (OHSS) in a fixed GnRH-antagonist versus GnRH-agonist protocol: randomised controlled trial including 1099 first IVF\/ICSI CYCLES Abstract of the 31st annual meeting of ESHRE I Lisbon, Portigal 2015 i94","DOI":"10.1093\/humrep\/dew051"},{"issue":"2","key":"10.1002\/14651858.CD001750.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejogrb.2004.11.005","article-title":"A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation: effect on safety and efficacy","volume":"120","author":"Xavier","year":"2005","journal-title":"Eurpean Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10815-009-9300-3","article-title":"IVF\/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study","volume":"2","author":"Ye","year":"2009","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0088|cit88","unstructured":"Ashrafi M Mohammadzadeh A Ezabadi Z Baghestani AR A comparative study of GnRH-ant and GnRH-ag protocols on IVF-ICSI in PCOD patients Book of Abstracts, 18th World Congress on Fertility and Sterility (IFFS 2004), Montreal Canada 2004"},{"issue":"6","key":"10.1002\/14651858.CD001750.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/humrep\/deq072","article-title":"Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation","volume":"25","author":"Bonduelle","year":"2010","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0090|cit90","unstructured":"Cattani R Cela V Cristello F Matteucci C Valentino V Artini P Efficacy and safety of gonadotrophin releasing hormone (GnRH) antagonist administration in infertile women during controlled ovarian hyperstimulation Gynecological Endocrinology 2000 212"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0091|cit91","first-page":"i103","article-title":"GnRH agonist versus GnRH antagonist in an IVF program: luteal phase hormonal characteristics","volume":"19","author":"Causio","year":"2004","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD001750.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/humrep\/del416","article-title":"Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multi centre randomized trial","volume":"22","author":"Crosignani","year":"2007","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD001750.pub4-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.fertnstert.2004.01.022","article-title":"A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years","volume":"81","author":"D'Amato","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0094|cit94","first-page":"107","article-title":"A comparative study of luteal estradiol pre-treatment in GnRH antagonist protocols and in micro dose flare protocols for poor responding patients","volume":"6","author":"Davar","year":"2012","journal-title":"Fertlity and Sterility"},{"issue":"9","key":"10.1002\/14651858.CD001750.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1093\/humrep\/dem171","article-title":"The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy","volume":"22","author":"Klerk","year":"2007","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/j.fertnstert.2010.07.329","article-title":"A new IVF stimulation protocol improves live birth rate in women with diminished ovarian reserve (DOR)","volume":"94","author":"Dudley","year":"September 2010","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD001750.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/humrep\/dei332","article-title":"Comparison of different treatment strategies in IVF with cumulative live birth over a given period of time as the primary end-point: methodological considerations on a randomized controlled non-inferiority trial","volume":"21","author":"Eijkemans","year":"2006","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.fertnstert.2007.04.006","article-title":"The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0099|cit99","first-page":"219","article-title":"Randomized prospective study on the effect of the addition of business cycles exogenous LH IVF\/ICSI GnRH antagonist predictors in patients with low response","volume":"28","author":"Evangelio","year":"2011","journal-title":"Revista Iberoamericana de Fertilidad"},{"issue":"2","key":"10.1002\/14651858.CD001750.pub4-BIB0100|cit100","first-page":"ii26","article-title":"Evaluation of GnRH agonists and antagonists in tertiary prevention of OHSS. Clinical, neurohormonal and vasoactive effects in the luteal phase in high risk patients","volume":"27","author":"Fabregues","year":"2012","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/09513590903215557","article-title":"Comparison of follicular fluid and serum cytokine concentrations in women undergoing assisted reproductive treatment with GnRH agonist long and antagonist protocols","volume":"26","author":"Ficicioglu","year":"2010","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.fertnstert.2004.07.613","article-title":"Gonadotropin-releasing hormone (GnRH)-agonist versus GnRH-antagonist in ovarian stimulation for assisted reproductive techniques: results of a prospective randomized trial","volume":"82 Suppl","author":"Freitas","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0103|cit103","first-page":"114","article-title":"Comparative evaluation of CC\/FSH with single dose antagonist versus conventional long protocol gonadotrophin stimulation for IVF in women with several attempts of failed IUI for unexplained infertility","volume":"18 Suppl 1","author":"Ghosh","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1016\/j.fertnstert.2011.07.687","article-title":"A prospective randomized study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF","volume":"96","author":"Gordts","year":"September 2011","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gyobfe.2009.04.028","article-title":"Efficiency of antagonist IVF cycle programming by estrogens","volume":"38","author":"Guivarc\u2019h-Lev\u00eaque","year":"2010","journal-title":"Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.mefs.2011.06.003","article-title":"Micro-dose flare-up gonadotrophin-releasing hormone (GnRH) agonist vs. flexible gonadotrophin-releasing hormone (GnRH) antagonist protocol in patient with poor ovarian reserve","volume":"16","author":"Ibrahim","year":"2011","journal-title":"Middle East Fertility Society Journal"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"S273","DOI":"10.1016\/j.fertnstert.2013.07.1137","article-title":"A prospective randomised controlled study comparing a low-cost antagonist protocol using oral ovulation inducing agents in IVF-ICSI cycles with a standard agonist long protocol","volume":"100","author":"Jindal","year":"October 2013","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00404-010-1828-z","article-title":"Comparison of mild and microdose GnRH agonist flare protocols on IVF outcome in poor responders","volume":"283","author":"Karimzadeh","year":"2011","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"12","key":"10.1002\/14651858.CD001750.pub4-BIB0109|cit109","first-page":"834","article-title":"Increased risk of early pregnancy loss and lower live birth rate with GnRH antagonists vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation","volume":"87","author":"Kdous","year":"2009","journal-title":"La Tunisie Medicale"},{"issue":"2","key":"10.1002\/14651858.CD001750.pub4-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00404-010-1401-9","article-title":"A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles","volume":"282","author":"Kim","year":"2010","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.fertnstert.2007.04.010","article-title":"Follicular fluid anti-M\u00fcllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles","volume":"89","author":"Lee","year":"2008","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/humrep\/14.4.885","article-title":"Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?","volume":"14","author":"Lin","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0113|cit113","first-page":"114","article-title":"GnRh antagonist versus GnRh agonist in good prognosis IVF patients","volume":"18 Suppl 1","author":"Londra","year":"2003","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0114|cit114","first-page":"i151","article-title":"Pituitary suppression with GnRH agonist on alternate days: can costs, effectiveness and comfort be brought together?","volume":"26","author":"Maldonado","year":"2011","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD001750.pub4-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.fertnstert.2013.01.095","article-title":"Cost-effectiveness comparison between pituitary down-regulation with a gonadotropin-releasing hormone agonist short regimen on alternate days and an antagonist protocol for assisted fertilization treatments","volume":"99","author":"Maldonado","year":"May 2013","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/j.fertnstert.2013.07.1695","article-title":"Microdose GnRH agonist flare-up versus flexible GnRH antagonist protocol in poor responders undergoing in-vitro fertilization (IVF) cycles: a randomized controlled trial","volume":"100","author":"Malhotra","year":"2013","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD001750.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/09513590.2012.730569","article-title":"Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI","volume":"29","author":"Mohsen","year":"2013","journal-title":"Gynecological Endocrinology"},{"issue":"8","key":"10.1002\/14651858.CD001750.pub4-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1080\/09513590701500994","article-title":"Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol","volume":"23","author":"Orvieto","year":"2007","journal-title":"Gynecological Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.fertnstert.2007.10.022","article-title":"GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity","volume":"90","author":"Orvieto","year":"2008","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD001750.pub4-BIB0120|cit120","first-page":"ii302","article-title":"A randomized prospective study of a gonadotropin-releasing hormone antagonist versus agonist microdose flare-up protocol in poor responder patients","volume":"27","author":"Ozdogan","year":"2012","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.fertnstert.2005.07.496","article-title":"Comparison of GnRH agonist and antagonist protocols among patients with mild-moderate endometriosis and endometrioma: a novel clinical approach","volume":"84 Suppl 1","author":"Pabuccu","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0122|cit122","first-page":"33","article-title":"Comparison between the GnRH antagonist ganirelix and the GnRH agonist buserelin: a prospective randomized controlled study","volume":"17","author":"Perino","year":"2002","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD001750.pub4-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00404-010-1429-x","article-title":"Impact of GnRH ovarian stimulation protocols on intra-cytoplasmic sperm injection outcomes","volume":"7","author":"Pinto","year":"2009","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD001750.pub4-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/humrep\/dem372","article-title":"Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint","volume":"23","author":"Polinder","year":"2008","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD001750.pub4-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/humrep\/deh832","article-title":"GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study","volume":"20","author":"Prapas","year":"2005","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0126|cit126","first-page":"i317","article-title":"New protocol of ovulation induction with GnRH antagonist compared with GnRH analogue long protocol in IVFET\/ICSI cycles","volume":"26","author":"Saini","year":"June 2010","journal-title":"Abstracts of the 26th Annual Meeting of ESHRE, Rome, Italy, 27 June \u2013 30 June, 2010"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0015-0282(03)01903-4","article-title":"Comparison of daily ganirelix administration to a long protocol agonist for controlled ovarian hyperstimulation in oocyte donors: the results of a prospective randomized controlled trial","volume":"80 Suppl 3","author":"Shamma","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0128|cit128","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1016\/j.fertnstert.2014.07.756","article-title":"Selection of an optimal controlled ovarian hyperstimulation method in relation to the number of antral follicles in patients less than 40 years old","volume":"102","author":"Tanaka","year":"September 2014","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.fertnstert.2013.07.1864","article-title":"Does single dose GNRH agonist administration after oocyte pick-up in antagonist cycles improve endometrial receptivity and pregnancy rates?","volume":"100","author":"Tiras","year":"October 2013","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0130|cit130","first-page":"i44","article-title":"The effect of the type of ovarian stimulation protocol on PGD results: a prospective randomised trial","volume":"28","author":"Verpoest","year":"2013","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1472-6483(10)61868-8","article-title":"Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles--a prospective, randomized study","volume":"7","author":"Vlaisavljevic","year":"2003","journal-title":"Reproductive Biomedicine Online"},{"issue":"5","key":"10.1002\/14651858.CD001750.pub4-BIB0132|cit132","first-page":"423","article-title":"Application of GnRH-antagonist to IVF-ET for patients with poor ovarian response","volume":"14","author":"Wang","year":"May 2008","journal-title":"National Journal of Andrology"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.fertnstert.2005.07.806","article-title":"Comparison of the luteal phase after pituitary suppression with GnRH-agonist versus GnRH antagonist in controlled ovarian stimulation","volume":"84 Suppl","author":"Willman","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD001750.pub4-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.fertnstert.2004.11.060","article-title":"A prospective randomized study comparing gonadotropin-releasing hormone agonists or gonadotropin-releasing hormone antagonists in couples with unexplained infertility and\/or mild oligozoospermia","volume":"83","author":"Zikopoulos","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"0. Advance Acce","key":"10.1002\/14651858.CD001750.pub4-BIB0135|cit135","first-page":"1\u201312","article-title":"Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles","volume":"0","author":"Toftager","year":"2016","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD001750.pub4-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1472-6483(10)61661-6","article-title":"Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol","volume":"10","author":"Al-Inany","year":"2005","journal-title":"Reproductive biomedicine online"},{"issue":"10","key":"10.1002\/14651858.CD001750.pub4-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/oxfordjournals.humrep.a019058","article-title":"Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (cetrorelix)","volume":"11","author":"Albano","year":"1996","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD001750.pub4-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2003.07.002","article-title":"Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome","volume":"80","author":"Bosch","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"767\u2013772","DOI":"10.1111\/j.1471-0528.1995.tb10840.x","article-title":"Diagnosis, prevention and management of ovarian hyperstimulation syndrome","volume":"102","author":"Brinsden","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0140|cit140","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001299","article-title":"Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles","author":"Daya","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0141|cit141","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review","volume":"8","author":"Delvigne","year":"2002","journal-title":"Human Reproduction Update"},{"issue":"9","key":"10.1002\/14651858.CD001750.pub4-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1093\/humrep\/13.9.2392","article-title":"Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist cetrorelix in healthy female volunteers","volume":"13","author":"Duijkers","year":"1998","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD001750.pub4-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0301-2115(95)02138-W","article-title":"Preserved pituitary response under ovarian stimulation with hMG and GnRH-antagonists (cetrorelix) in women with tubal infertility","volume":"61","author":"Felberbaum","year":"1995","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1440\u20131447","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"Journal of Clinical Endocrinology"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","author":"Golan A. Ron-El","year":"1989","journal-title":"Obstet. Gynecol. Surv"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0148|cit148","unstructured":"McMaster University (developed by Evidence Prime, Inc.). Available from www.gradepro.org GRADEpro Guideline Develoopment Tool 2015"},{"issue":"4","key":"10.1002\/14651858.CD001750.pub4-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.fertnstert.2007.07.1354","article-title":"Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis","volume":"90","author":"Griesinger","year":"2008","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0151|cit151","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0152|cit152","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0015-0282(16)55430-2","article-title":"The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized trials","volume":"58","author":"Hughes","year":"1992","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1093\/humrep\/dem270","article-title":"Are GnRH antagonists comparable to agonists for use in IVF?","volume":"11","author":"Huirne","year":"2007","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1210\/jc.2003-030805","article-title":"Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles.","volume":"88","author":"Kolibianakis","year":"2003","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"issue":"7","key":"10.1002\/14651858.CD001750.pub4-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/humrep\/deh272","article-title":"Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists","volume":"19","author":"Kolibianakis","year":"2004","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD001750.pub4-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humupd\/dml038","article-title":"Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis","volume":"12","author":"Kolibianakis","year":"2006","journal-title":"Human reproduction update"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0158|cit158","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14647270601111239","article-title":"Review of the evidence base strategies to prevent ovarian hyperstimulation syndrome","volume":"10","author":"Mathur","year":"2007","journal-title":"Human Fertility"},{"issue":"9128","key":"10.1002\/14651858.CD001750.pub4-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1999","journal-title":"The Lancet"},{"issue":"7","key":"10.1002\/14651858.CD001750.pub4-BIB0161|cit161","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(65)90636-7","article-title":"Thromboembolic phenomena after ovarian stimulation with human gonadotrophins","volume":"2","author":"Mozes","year":"1965","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","article-title":"Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment","volume":"58","author":"Navot","year":"1992","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(16)56933-7","article-title":"The single or dual administration of the gonadotrophin-releasing hormone antagonist cetrorelix in an in-vitro fertilisation-embryo transfer program","volume":"62","author":"Olivennes","year":"1994","journal-title":"Fertility and Sterility"},{"issue":"9","key":"10.1002\/14651858.CD001750.pub4-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/humrep\/13.9.2411","article-title":"The use of GnRH antagonist (cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2mg","volume":"13","author":"Olivennes","year":"1998","journal-title":"Human Reproduction (Oxford,England)"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0166|cit166","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0167|cit167","first-page":"131","article-title":"Classification, pathophysiology and management of ovarian hyperstimulation syndrome","volume-title":"Brinsden P (ed) In-Vitro Fertilization and Assisted Reproduction","author":"Rizk","year":"1999"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"Epub 24 March","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"64\u20138","DOI":"10.1159\/000290062","article-title":"Characteristics of progesterone changes in women with subtle progesterone rise in recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonist cycle","volume":"70","author":"Seow","year":"2010","journal-title":"Gynecologic and Obstetric Investigation"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0015-0282(02)03157-6","article-title":"The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation","volume":"77","author":"Shoham","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD001750.pub4-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/humrep\/deq059","article-title":"Avoidance of weekend oocyte retrievals during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes","volume":"25","author":"Tremellen","year":"2010","journal-title":"Humanan Reproduction"},{"key":"10.1002\/14651858.CD001750.pub4-BIB0173|cit173","article-title":"Could mild\/minimal ovarian stimulation-IVF displace conventional IVF in poor responder women undergoing IVF\/ICSI treatment cycles: systematic review & meta-analysis","volume":"27","author":"Youssef","year":"2012","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD001750.pub4-BIB0174|cit174","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","author":"Al-Inany","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001750.pub4-BIB0175|cit175","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001750.pub2","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception","author":"Al-Inany","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD001750.pub4-BIB0176|cit176","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","author":"Al-Inany","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001750.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T07:13:52Z","timestamp":1715066032000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001750.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":176,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001750.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,29]]}}}